{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:16:58Z","timestamp":1792459018983,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s42000-022-00423-5","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T05:03:05Z","timestamp":1670389385000},"page":"131-138","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Adrenal findings in FDG-PET: analysis of a cohort of 1021 patients from a cancer center"],"prefix":"10.1007","volume":"22","author":[{"given":"Joana","family":"Maciel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Cavaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Fraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helder","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7119-5058","authenticated-orcid":false,"given":"Joana","family":"Sim\u00f5es-Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,7]]},"reference":[{"key":"423_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12020-014-0440-6","volume":"49","author":"A Kandathil","year":"2015","unstructured":"Kandathil A, Wong KK, Wale DJ, Zatelli MC, Maffione AM, Gross MD, Domenico R (2015) Metabolic and anatomic characteristics of benign and malignant adrenal masses on positron emission tomography\/computed tomography\u202f: a review of literature. Endocrine 49:6\u201326. https:\/\/doi.org\/10.1007\/s12020-014-0440-6","journal-title":"Endocrine"},{"key":"423_CR2","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1097\/MNM.0000000000000712","volume":"38","author":"E Ciftci","year":"2017","unstructured":"Ciftci E, Turgut B, Cakmakcilar A, Erturk SA (2017) Diagnostic importance of 18 F-FDG PET\/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions. Nucl Med Commun 38:788\u2013794. https:\/\/doi.org\/10.1097\/MNM.0000000000000712","journal-title":"Nucl Med Commun"},{"key":"423_CR3","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3322\/caac.21565","volume":"69","author":"K Miller","year":"2019","unstructured":"Miller K, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, Jemal A, Kramer JL, Siegel RL (2019) Cancer treatment and survivorship statistics. CA Cancer J Clin 69:363\u2013385. https:\/\/doi.org\/10.3322\/caac.21565","journal-title":"CA Cancer J Clin"},{"key":"423_CR4","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1067\/msy.2001.118369","volume":"130","author":"JT Lenert","year":"2001","unstructured":"Lenert JT, Barnett CC, Kudelka AP, Sellin RV, Gagel RF, Prieto VG, Skibber JM, Ross MI, Pisters PW, Curley SA et al (2001) Evaluation and surgical resection of adrenal masses in patients with a history of extra-adrenal malignancy. Surgery 130:1060\u20131067. https:\/\/doi.org\/10.1067\/msy.2001.118369","journal-title":"Surgery"},{"key":"423_CR5","doi-asserted-by":"publisher","first-page":"956","DOI":"10.2214\/AJR.08.1431","volume":"192","author":"GWL Boland","year":"2009","unstructured":"Boland GWL, Blake MA, Holalkere NS, Hahn PF (2009) PET\/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients. AJR Am J Roentgeno 192:956\u2013962. https:\/\/doi.org\/10.2214\/AJR.08.1431","journal-title":"AJR Am J Roentgeno"},{"key":"423_CR6","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1007\/s00259-014-2844-1","volume":"41","author":"J Kunikowska","year":"2014","unstructured":"Kunikowska J, Matyskiel R, Toutounchi S, Grabowska-Derlatka L, Koperski L (2014) What parameters from 18 F-FDG PET\/CT are useful in evaluation of adrenal lesions. Eur J Nucl Mol Imaging 41:2273\u20132280. https:\/\/doi.org\/10.1007\/s00259-014-2844-1","journal-title":"Eur J Nucl Mol Imaging"},{"key":"423_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2214\/AJR.10.5342","volume":"197","author":"M Perri","year":"2011","unstructured":"Perri M, Erba P, Volterrani D, Guidoccio F, Lazzeri E, Caramella D, Mariani G (2011) Adrenal masses in patients with cancer: PET\/CT characterization with combined CT histogram and standardized uptake value PET analysis. Nucl Med Mol Imaging 197:209\u2013216. https:\/\/doi.org\/10.2214\/AJR.10.5342","journal-title":"Nucl Med Mol Imaging"},{"issue":"2","key":"423_CR8","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0467","volume":"175","author":"M Fassnacht","year":"2016","unstructured":"Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, Tabarin A, Terzolo M, Tsagarakis S, Dekkers OM (2016) Management of adrenal incidentalomas\u202f: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 175(2):G1\u2013G34. https:\/\/doi.org\/10.1530\/EJE-16-0467","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"423_CR9","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-18-0608","volume":"179","author":"M Fassnacht","year":"2018","unstructured":"Fassnacht M, Dekkers OM, Else T, Baudin E, Berruti A (2018) European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 179(4):G1\u2013G46. https:\/\/doi.org\/10.1530\/EJE-18-0608","journal-title":"Eur J Endocrinol"},{"key":"423_CR10","first-page":"32","volume":"47","author":"U Metser","year":"2006","unstructured":"Metser U, Miller E, Lerman H, Lievshitz G, Avital S, Even-sapir E (2006) 18F-FDG PET\/CT in the evaluation of adrenal masses. J Nucl Med 47:32\u201337","journal-title":"J Nucl Med"},{"key":"423_CR11","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.2214\/AJR.07.3447","volume":"191","author":"R Vikram","year":"2008","unstructured":"Vikram R, Yeung HDW, Macapinlac HA, Iyer RB (2008) Utility of PET\/CT in differentiating benign from malignant adrenal. AJR Am J Roentgenol. 191:1545\u20131551. https:\/\/doi.org\/10.2214\/AJR.07.3447","journal-title":"AJR Am J Roentgenol."},{"key":"423_CR12","doi-asserted-by":"publisher","unstructured":"Okada M, Shimono T, Komeya Y, Ando R, Kagawa Y, Katsube T, Kuwabara M, Yagyu Y, Kumano S, Imaoka I et al (2009) Adrenal masses : the value of additional fluorodeoxyglucose-positron emission tomography \/ computed tomography (FDG-PET\/CT) in differentiating between benign and malignant lesions. Ann Nucl Med:349\u2013354. https:\/\/doi.org\/10.1007\/s12149-009-0246-4","DOI":"10.1007\/s12149-009-0246-4"},{"issue":"2","key":"423_CR13","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1148\/radiol.2502080219","volume":"250","author":"MJ Brady","year":"2009","unstructured":"Brady MJ, Thomas J, Wong TZ, Franklin KM, Ho LM, Paulson EK (2009) Adrenal nodules at FDG PET \/ CT in patients known to have or suspected of having lung cancer : a proposal for an efficient diagnostic algorithm. Radiology 250(2):523\u2013530. https:\/\/doi.org\/10.1148\/radiol.2502080219","journal-title":"Radiology"},{"key":"423_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/MNM.0b013e32834199e7","volume":"32","author":"PO Kara","year":"2011","unstructured":"Kara PO, Kara T, Gedik GK, Kara F, Sahin O, Gunay EC, Sari O (2011) The role of fluorodeoxyglucose-positron emission tomography \/ computed tomography in differentiating between benign and malignant adrenal lesions. Nucl Med Commun 32:106\u2013112. https:\/\/doi.org\/10.1097\/MNM.0b013e32834199e7","journal-title":"Nucl Med Commun"},{"key":"423_CR15","doi-asserted-by":"publisher","first-page":"424","DOI":"10.7326\/0003-4819-138-5-200303040-00013","volume":"138","author":"MM Grumbach","year":"2003","unstructured":"Grumbach MM, Biller BMK, Braunstein GD, Campbell KK, Carney J\u00c1 et al (2003) Management of the clinically inapparent adrenal mass. Ann Intern Med 138:424\u2013429. https:\/\/doi.org\/10.7326\/0003-4819-138-5-200303040-00013","journal-title":"Ann Intern Med"},{"key":"423_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1530\/eje.0.1490273","volume":"149","author":"L Barzon","year":"2003","unstructured":"Barzon L, Sonino N, Fallo F, Palu G, Boscaro M (2003) Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 149:273\u2013285. https:\/\/doi.org\/10.1530\/eje.0.1490273","journal-title":"Eur J Endocrinol"},{"key":"423_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00259-005-1915-8","volume":"33","author":"S Jana","year":"2006","unstructured":"Jana S, Zhang T, Milstein DM, Isasi CR, Blaufox MD (2006) FDG-PET and CT characterization of adrenal lesions in cancer patients. Eur J Nucl Med Mol Imaging 33:29\u201335. https:\/\/doi.org\/10.1007\/s00259-005-1915-8","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"423_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1148\/radiol.11100569","volume":"259","author":"GWL Boland","year":"2011","unstructured":"Boland GWL, Dwamena BA, Goehler AG, Blake MA, Rcsi FFR, Hahn PF, Scott JA et al (2011) Characterization of adrenal masses by using FDG PET : A systematic review and meta-analysis of diagnostic test performance. Radiology 259(1):117\u2013126. https:\/\/doi.org\/10.1148\/radiol.11100569","journal-title":"Radiology"},{"key":"423_CR19","first-page":"1795","volume":"42","author":"M Yun","year":"2001","unstructured":"Yun M, Kim W, Alnafisi N, Lacorte L, Jang S, Alavi A (2001) 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med. 42:1795\u20131799","journal-title":"J Nucl Med."},{"key":"423_CR20","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1210\/jc.2008-2302","volume":"94","author":"L Groussin","year":"2009","unstructured":"Groussin L, Bonardel G, Silv\u00e9ra S, Tissier F, Coste J, Abiven G, Lib\u00e9 R, Bienvenu M, Alberini J, Salenave S et al (2009) 18F-fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors : a prospective study in 77 operated patients. J Clin Endocrinol Metab 94:1713\u20131722. https:\/\/doi.org\/10.1210\/jc.2008-2302","journal-title":"J Clin Endocrinol Metab"},{"key":"423_CR21","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s12149-013-0730-8","volume":"27","author":"H Watanabe","year":"2013","unstructured":"Watanabe H, Kanematsu M, Goshima S, Kondo H, Kawada H, Noda Y, Moriyama N (2013) Adrenal-to-liver SUV ratio is the best parameter for differentiation of adrenal metastases from adenomas using 18F-FDG PET\/TC. Ann Nucl Med. 27:648\u2013653. https:\/\/doi.org\/10.1007\/s12149-013-0730-8","journal-title":"Ann Nucl Med."},{"key":"423_CR22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JWM Lenders","year":"2014","unstructured":"Lenders JWM, Duh Q, Eisenhofer G, Grebe SKG, Murad MH (2014) Pheochromocytoma and paraganglioma : an endocrine society clinical practice guideline. JCEM 99:191\u2013242. https:\/\/doi.org\/10.1210\/jc.2014-1498","journal-title":"JCEM"},{"key":"423_CR23","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1007\/s00259-010-1471-8","volume":"37","author":"C Ansquer","year":"2010","unstructured":"Ansquer C, Secigliano S, Miralli\u00e9 E, Ta\u00efeb D, Brunaud L, Sebag F, Leux C, Drui D, Dupas B, Renaudin K et al (2010) 18F -FDG PET \/ CT in the characterization and surgical decision concerning adrenal masses : a prospective multicentre evaluation. Eur J Nucl Med Mol Imaging 37:1669\u20131678. https:\/\/doi.org\/10.1007\/s00259-010-1471-8","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"423_CR24","doi-asserted-by":"publisher","unstructured":"Ebbehoj A, Li D, Kaur RJ, Zhang C, Singh S, Li T, Atkinson E, Achenbach S, Khosla S Arlt W et al (2020) Epidemiology of adrenal tumours in olmsted county, Minnesota, USA : a population-based cohort study. Lancet Diabetes Endocrinol 8:894\u2013902. https:\/\/doi.org\/10.1016\/S2213-8587(20)30314-4","DOI":"10.1016\/S2213-8587(20)30314-4"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-022-00423-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-022-00423-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-022-00423-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T03:34:09Z","timestamp":1678764849000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-022-00423-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,7]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["423"],"URL":"https:\/\/doi.org\/10.1007\/s42000-022-00423-5","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,7]]},"assertion":[{"value":"16 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of our center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was not mandatory by our Ethics Committee as this was a retrospective analysis of anonymous data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}